Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
SNAP-8 structure

SNAP-8

Cosmetic & Sexual
Phase 2 Research
55%
Low Risk
1/5

Dosing Protocol

Typical Dose 50 mg
Range 30 - 100 mg

Pharmacokinetics

Half-Life --
Onset 1.0 days
Peak 30.0 days
Duration 30.0 days
Bioavailability 0%
Primary Route Topical

Administration

Routes Topical
Timing Morning, Evening

Special Instructions

Enhanced version of Argireline (8 amino acids vs 6). Apply to expression lines on clean, dry skin. Better penetration than Argireline. Often combined with Matrixyl for comprehensive anti-aging.